J J Hernández RuizA M C Romero MalacaraL A López MotaM J Pérez Guzmán2026-03-222026-03-22202410.1016/j.jneuroim.2024.578503https://doi.org/10.1016/j.jneuroim.2024.578503https://andeanlibrary.org/handle/123456789/85944enMyasthenia gravisFollicular phaseImmunologyDiseaseMedicineTherapeutic development towards T follicular helper cells as a molecular target in myasthenia gravis diseasereview